Jesus Martin-Garcia is the founder of GeNeuro. GeNeuro has raised $36M in total funding. Latest round: IPO. Based in Plan-les-Ouates, Geneva, Switzerland.
Jesús Martin-Garcia is the Chairman and CEO of GeNeuro, a Swiss biotechnology company. He successfully led GeNeuro's IPO in April 2016, raising €33 million. He has overseen the progression of the company's flagship product GNbAC1 into Phase IIb clinical trials.
Full founder directory · Investor directory · Company funding database · Fundraising library